Multicenter, Retrospective, Observational Study to Evaluate Clinical and Economic Outcomes of Patients With MRSA Hospital-Acquired Pneumonia Treated With Linezolid Or Vancomycin.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Linezolid (Primary) ; Vancomycin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 08 Jul 2013 Planned end date changed from 1 Jan 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov record.
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Feb 2013 Primary emdpoint amended as reported by ClinicalTrials.gov.